High initial drug doses may reduce cancer drug resistance

Download PDF Copy

Editorial Checklist

Reviewed

Aging-USAug 6 2024

NewsGuard 100/100 Score

On July 28, 2024, Mikhail V. Blagosklonny M.D., Ph.D., from Roswell Park Comprehensive Cancer Center published a new editorial in Volume 16, Issue 14 of Aging (listed by MEDLINE/PubMed as "Aging (Albany NY)" and "Aging-US" by Web of Science), entitled, "Targeted cancer therapy: the initial high concentration may slow down the selection for resistance."

"Unfortunately, any targeted therapy is, always, started with low levels of the drug in the organism, selecting for drug resistance. One should propose that initial drug levels must be maximized, and durations may be minimized, ideally, as portions of preemptive combination of targeted drugs."

Source:

Journal reference:

Blagosklonny, M. V. (2024). Targeted cancer therapy: the initial high concentration may slow down the selection for resistance. Aging. doi.org/10.18632/aging.206046.

Posted in: Medical Research News | Medical Condition News

Tags: Aging, Brain, Brain Metastases, Cancer, Cancer Therapy, covid-19, Drugs, Lung Cancer, pH, Rapamycin, Research

Comments (0)

Download PDF Copy

Suggested Reading

AI-powered tool predicts gene activity in cancer cells from biopsy images

AI-powered tool predicts gene activity in cancer cells from biopsy images

How different types of bread impact cancer risk

How different types of bread impact cancer risk

Innovative urine test could improve pancreatic cancer survival rates

Innovative urine test could improve pancreatic cancer survival rates

Air pollution linked to head and neck cancer risk

Air pollution linked to head and neck cancer risk

Neoantigen DNA vaccines improve survival and immunity in triple-negative breast cancer patients

Neoantigen DNA vaccines improve survival and immunity in triple-negative breast cancer patients

MRI-guided SBRT reduces side effects in prostate cancer treatment

MRI-guided SBRT reduces side effects in prostate cancer treatment

Scientists discover key genetic factors behind testicular cancer

Scientists discover key genetic factors behind testicular cancer

Study uncovers why white button mushrooms may help prevent prostate cancer progression

Study uncovers why white button mushrooms may help prevent prostate cancer progression

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.

Post a new comment

Post

Hi, I'm Azthena, you can trust me to find commercial scientific answers from News-Medical.net.

To start a conversation, please log into your AZoProfile account first, or create a new account.

Registered members can chat with Azthena, request quotations, download pdf's, brochures and subscribe to our related newsletter content.

A few things you need to know before we start. Please read and accept to continue.

Use of “Azthena” is subject to the terms and conditions of use as set out by OpenAI.
Content provided on any AZoNetwork sites are subject to the site Terms & Conditions and Privacy Policy.
Large Language Models can make mistakes. Consider checking important information.

I understand, and agree to receive occasional emails about Azthena such as usage tips and new feature announcements.

Please check the box above to proceed.

Great. Ask your question.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...

Study shows cannabis as a genotoxic substance with cancer risks